2 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Spasm: new trials by email Literature Review of Spasm trials Research Report on Spasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Effect of Systemic Proteolytic Enzyme Therapy on Postoperative Inflammatory Response and QoL After Surgical Extraction of Impacted Mandibular Third Molars systemic proteolytic enzyme (Tibrolin), Amoxicillin 500mg+metronidazole 500mg+ doliprane 100mg - Post Operative Pain | Phase 3 | Unknown | University of Baghdad | 55 | 2024-05-08 | 2024-05-08 |
| Wumeiwan Jiawei Fang Use in Patients With Blepharospasm Wumeiwan Jiawei Fang, botulinum toxin A - Dry Eye Syndromes, Meige Syndrome | Phase 2 / Phase 3 | Unknown | China Academy of Chinese Medical Sciences | 80 | 2018-01-12 | 2022-11-17 |
Blepharospasm (1) · Dry Eye Syndromes (1) · Meige Syndrome (1) · Pain (1) · Pain, Postoperative (1) · Trismus (1)
Nervous System Diseases (2) · Neurologic Manifestations (2) · Neuromuscular Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Basal Ganglia Diseases (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Dystonic Disorders (1) · Eye Diseases (1) · Eyelid Diseases (1) · Lacrimal Apparatus Diseases (1) · Movement Disorders (1) · Pathologic Processes (1) · Postoperative Complications (1)
Amoxicillin (1) · Botulinum Toxins, Type A (1) · Metronidazole (1)
China Academy of Chinese Medical Sciences (1) · University of Baghdad (1)
China (1) · Iraq (1)